PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
17/07/26	NT$11.70	-2.50%	267,143
16/07/26	NT$12.00	-1.23%	89,384
15/07/26	NT$12.15	+2.53%	142,440
14/07/26	NT$11.85	-0.42%	207,833
13/07/26	NT$11.90	-0.83%	169,898

End-of-day quote Taiwan S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Taiwan S.E. Other stock markets 17/07/2026			5-day change	1st Jan Change
11.70 ^TWD	-2.50%		-2.50%	-13.33%

06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	2.32B 71.71M 62.67M 57.83M 53.3M 100M 6.91B 103M 691M 272M 3.38B 269M 263M 11.64B	P/E 2024	-45.4x	P/E 2025	-46.1x
Enterprise Value	1.27B 39.34M 34.38M 31.72M 29.24M 55.11M 3.79B 56.34M 379M 149M 1.86B 148M 144M 6.39B	EV / Sales 2024	14.8x	EV / Sales 2025	12.1x
Free-Float	75.64%	Yield 2024 *	-	Yield 2025	-

06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-10	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
22/09/25	PhytoHealth Corporation(TWSE:4108) dropped from S&P Global BMI Index	CI
13/08/25	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
06/05/25	PhytoHealth, German Firm to Jointly Market Rectal Pain Drug in EU	MT
05/05/25	PhytoHealth Corporation Signs Letter of Intent with Aristo Pharma GmbH	CI
04/05/25	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Member of Audit Committee and Remuneration Committee	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Independent Director	CI
27/02/25	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
11/11/24	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

09/08/22	PhytoHealth : BOD approve the 2022 second quarter consolidated financial report	PU
05/07/22	Phytohealth : is invited to Online Investor Conference held by KGI Securities	PU
24/05/22	PhytoHealth : Important resolutions of company's 2022 shareholders' meeting.	PU
08/04/22	PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.	PU
09/03/22	PhytoHealth : Announcement of the financial information of February 2022	PU

PhytoHealth Corporation Stock

Stocks

4108

TW0004108006

Pharmaceuticals

Valuation: PhytoHealth Corporation

Chart: PhytoHealth Corporation

Latest news : PhytoHealth Corporation

Press Releases: PhytoHealth Corporation

Quotes and Performance

Course Extremes

Managers and Directors: PhytoHealth Corporation

Biopharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	-2.50%
1 week	-2.50%
Current month	-3.31%
1 month	-2.50%
3 months	-7.51%
6 months	-16.13%
Current year	-13.33%

1 week	11.55	12.2
1 month	11.55	12.9
Current year	11.4	15.25
1 year	11.4	17.9
3 years	11	24.3
5 years	11	25.25
10 years	10.25	41.05

Manager	Title	Age	Since
I Lin Lee CEO	Chief Executive Officer	-	13/06/2017
Chih Yuan Huang DFI	Director of Finance/CFO	-	11/05/2021
Teng Hsu Wang CTO	Chief Tech/Sci/R&D Officer	-	30/07/2021

Director	Title	Age	Since
Ching Chung Tsai BRD	Director/Board Member	-	12/06/2014
Yue Ju Lai BRD	Director/Board Member	-	16/03/2010
Yi Li Lee CHM	Chairman	55	26/05/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHYTOHEALTH CORPORATION	-2.50%	-2.50%	-10.34%	-49.57%	71.71M
REGENERON PHARMACEUTICALS, INC.	-0.33%	+1.83%	+23.03%	-6.22%	68.85B
UCB	+0.67%	+0.93%	+37.53%	+198.53%	52.13B
SAMSUNG BIOLOGICS CO.,LTD.	+0.94%	+39.60%	+39.60%	+39.60%	43.46B
CSL LIMITED	+1.12%	+0.35%	-50.35%	-52.35%	41.24B
BIOGEN INC.	-1.40%	+3.43%	+60.07%	-26.01%	30.41B
MODERNA, INC.	-2.11%	-9.45%	+91.99%	-49.58%	24.53B
INCYTE CORPORATION	+0.51%	+0.46%	+70.08%	+91.96%	23.42B
INNOVENT BIOLOGICS, INC.	-5.57%	-0.84%	-0.17%	+174.11%	19.75B
SWEDISH ORPHAN BIOVITRUM AB	-0.86%	-1.99%	+68.42%	+124.39%	16.57B
Average	-0.95%	-0.89%	+32.98%	+44.49%	32.04B
Weighted average by Cap.	-0.34%	-0.07%	+31.34%	+47.20%

	2024	2025
Net sales	154M 4.74M 4.14M 3.82M 3.52M 6.64M 456M 6.79M 45.67M 17.96M 223M 17.8M 17.41M 769M	135M 4.15M 3.63M 3.35M 3.09M 5.82M 400M 5.95M 40.03M 15.74M 196M 15.6M 15.25M 674M
Net income	-73.5M -2.27M -1.98M -1.83M -1.69M -3.18M -218M -3.25M -21.86M -8.6M -107M -8.52M -8.33M -368M	-58.2M -1.8M -1.57M -1.45M -1.33M -2.52M -173M -2.57M -17.31M -6.81M -84.7M -6.74M -6.6M -292M
Net Debt	-1.06B -32.77M -28.64M -26.42M -24.36M -45.91M -3.16B -46.93M -316M -124M -1.55B -123M -120M -5.32B	-1.05B -32.37M -28.29M -26.1M -24.06M -45.35M -3.12B -46.36M -312M -123M -1.53B -122M -119M -5.26B